Salvage chemotherapy with carboplatin plus weekly docetaxel in patients (pts) with castration- and docetaxel-resistant prostate cancer (DRPC): Associations of patient and disease characteristics with overall survival (OS) - Reuter, C W; Morgan, M A; Grunwald, V (ASCO Meeting Abstracts, 2014)
et al.